Showing results (241-250 of 463) with videos related to

Sort By:
Pageof 47
Japanese Journal of Clinical Oncology|November 14, 2013
Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junctionMasayoshi Yamada, Ryoji Kushima, Ichiro Oda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Erlotinib plus gemcitabine combination therapy in patients with unresectable advanced pancreatic cancer - a single-institution experience]Yutaka Takeda, Shin Nakahira, Yoshiteru Katsura, et al.
British Journal of Cancer|March 23, 2016
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodiesNaoki Takahashi, Satoru Iwasa, Hirokazu Taniguchi, et al.
The Journal of Pathology|March 1, 2016
Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenomaShigeki Sekine, Satoshi Yamashita, Taro Tanabe, et al.
International Journal of Hematology|April 18, 2016
Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphomaShinichi Makita, Dai Maruyama, Akiko Miyagi Maeshima, et al.
Cancer Letters|December 3, 2014
Frequent involvement of chromatin remodeler alterations in gastric field cancerizationHideyuki Takeshima, Tohru Niwa, Takamasa Takahashi, et al.
Surgical Neurology International|January 2, 2020
A rare case of brain metastasis from poorly differentiated small bowel adenocarcinomaErika Yamazawa, Yoshitaka Honma, Kaishi Satomi, et al.
Internal Medicine (Tokyo, Japan)|September 3, 2013
Epstein-Barr virus-associated enteropathy as a complication of infectious mononucleosis mimicking peripheral T-cell lymphomaShinobu Tamura, Dai Maruyama, Akiko Miyagi Maeshima, et al.
The American Journal of Surgical Pathology|February 22, 2013
Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapyAkiko M Maeshima, Hirokazu Taniguchi, Suguru Fukuhara, et al.
BMC Research Notes|April 30, 2014
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancerNaoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Pageof 47